Caplin Point Laboratories has informed that a meeting of the Board of Directors of the Company will be held on May 12, 2022, to consider and approve: the annual audited financial results of the Company for the year ended March 31, 2022 (both standalone & consolidated) and. declaration of Interim Dividend, if any, for the FY 2021-22 and fixation of record date for determining the eligibility of shareholders. As informed earlier vide letter dated March 28, 2022, the trading window for dealing in the Company's scrips by the Directors and Designated Employees of the Company will remain closed from April 01, 2022 to May 14, 2022 (both days inclusive), in terms of the Company's Code of Conduct to regulate, monitor and report trading by insiders, read with SEBI (Prohibition of Insider Trading) Regulations, 2015.
The above information is a part of company’s filings submitted to BSE.